References
- Cristofanilli M, Budd GT, Ellis MJ et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351(8), 781–791 (2004).
- Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 23(5), 573–581 (2013).
- Kummar S, Chen A, Ji J et al. Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. Cancer Res. 71(17), 5626–5634 (2011).
- Kummar S, Ji J, Morgan R et al. A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas. Clin. Cancer Res. 18(6), 1726–1734 (2012).
- Tarumi S, Gotoh M, Kasai Y et al. Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer. J. Cardiothorac. Surg. 8, 175 (2013).
- Maltez-da Costa M, de la Escosura-Muñiz A, Nogués C, Barrios L, Ibáñez E, Merkoçi A. Simple monitoring of cancer cells using nanoparticles. Nano Lett. 12(8), 4164–4171 (2012).
- Shi G, Cui W, Benchimol M et al. Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles. PLoS ONE 8(3), e58017 (2013).
- Wu S, Liu Z, Liu S, Lin L, Yang W, Xu J. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions. Clin. Chem. Lab. Med. 1–9 (2013).
- Casavant BP, Mosher R, Warrick JW et al. A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells. Methods 64(2), 137–134 (2013).
- Warkiani ME, Guan G, Luan KB et al. Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells. Lab Chip doi:10.1039/C3LC50617G (2013) ( Epub ahead of print).
- Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105(9), 1338–1341 (2011).
- Yu M, Bardia A, Wittner BS et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119), 580–584 (2013).
- Jung SY, Ahn S, Seo E, Lee SJ. Detection of circulating tumor cells via an X-ray imaging technique. J. Synchrotron. Radiat. 20(Pt 2), 324–331 (2013).
- Hossain M, Luo Y, Sun Z et al. X-ray enabled detection and eradication of circulating tumor cells with nanoparticles. Biosens. Bioelectron. 38(1), 348–354 (2012).
- Fan ZC, Yan J, Liu GD et al. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis. Cancer Res. 72(10), 2683–2691 (2012).
- Marchesi V. Lung cancer: ALK status of NSCLC reflected in CTCs. Nat. Rev. Clin. Oncol. 10(7), 366 (2013).
- Lee HJ, Oh JH, Oh JM et al. Efficient isolation and accurate in situ analysis of circulating tumor cells using detachable beads and a high-pore-density filter. Angew. Chem. Int. Ed. Engl. 52(32), 8337–8340 (2013).
- Pailler E, Adam J, Barthélémy A et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J. Clin. Oncol. 31(18), 2273–2281 (2013).
- Cho WC. Circulating microRNAs as minimally invasive biomarkers for cancer theragnosis and prognosis. Front. Genet. 2, 7 (2011).
- Liu N, Cui RX, Sun Y et al. A four-serum microRNA signature predicts survival in patients with nasopharyngeal carcinoma. Int. J. Cancer doi:10.1002/ijc.28468 (2013) ( Epub ahead of print).
- Madhavan D, Zucknick M, Wallwiener M et al. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin. Cancer Res. 18(21), 5972–5982 (2012).
- Sieuwerts AM, Mostert B, Bolt-de Vries J et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin. Cancer Res. 17(11), 3600–3618 (2011).
- Mostert B, Kraan J, Sieuwerts AM et al. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes. Cancer Lett. 319(1), 49–55 (2012).
- Kang JH, Krause S, Tobin H, Mammoto A, Kanapathipillai M, Ingber DE. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab. Chip 12(12), 2175–2181 (2012).
- Powell AA, Talasaz AH, Zhang H et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7(5), e337788 (2012).